Glen Eagle Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Glen Eagle Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-50	Closed	-$3.48K	–	1170
2024 Q3	$3.48K	Hold	50	–	–	﹤0.01%	827
2024 Q2	$3.36K	Hold	50	–	–	﹤0.01%	822
2024 Q1	$3.45K	Hold	50	–	–	﹤0.01%	833
2023 Q4	$3.11K	Hold	50	–	–	﹤0.01%	804
2023 Q3	$2.81K	Hold	50	–	–	﹤0.01%	805
2023 Q2	$2.52K	Hold	50	–	–	﹤0.01%	841
2023 Q1	$2.73K	Hold	50	–	–	﹤0.01%	809
2022 Q4	$3.13K	Hold	50	–	–	﹤0.01%	805
2022 Q3	$3.52K	Buy	+50	New	+$3.45K	﹤0.01%	761

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Glen Eagle Advisors's AXNX Position: Q4 2024 in Review

Glen Eagle Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 50 shares — an estimated $3.48K sold.

Glen Eagle Advisors first reported a position in AXNX in Q3 2022 and held it in 9 quarters. The position peaked at $3.52K in Q3 2022. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Glen Eagle Advisors reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Glen Eagle Advisors sold 50 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $3.48K.
Glen Eagle Advisors first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 9 quarters.
Glen Eagle Advisors's Axonics, Inc. Common Stock position peaked at $3.52K in Q3 2022.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Glen Eagle Advisors's 13F filing for Q4 2024, filed 18 Feb 2025.